Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Aide

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
EJNMMI Research|March 21, 2020
HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological <sup>18</sup>F-FDG anal uptakeNicolas Aide, Laure-Eugénie Tainturier, Cathy Nganoa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2010
18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor modelNicolas Aide, Kathryn Kinross, Carleen Cullinane, et al.
Clinical Nuclear Medicine|February 8, 2012
Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experienceRenaud Ciappuccini, Julia Morera, Pierre Pascal, et al.
Plos One|September 7, 2016
Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid CancerRenaud Ciappuccini, Nicolas Aide, David Blanchard, et al.
Diagnostics (Basel, Switzerland)|August 7, 2021
<sup>18</sup>F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University HospitalJean-Baptiste Le Goubey, Charline Lasnon, Ines Nakouri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 12, 2021
Assessing immune organs on <sup>18</sup>F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patientsKevin Prigent, Charline Lasnon, Emilien Ezine, et al.
Molecular Imaging and Biology|July 16, 2010
A dual radiologic contrast agent protocol for 18F-FDG and 18F-FLT PET/CT imaging of mice bearing abdominal tumorsNicolas Aide, Kathryn Kinross, Jean-Mathieu Beauregard, et al.
Nuclear Medicine Communications|May 9, 2013
Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenograftsPierre Bohn, Romain Modzelewski, Jean Rouvet, et al.
Nuclear Medicine Communications|April 2, 2013
Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesionsJean-Mathieu Beauregard, Anne-Laure Giraudet, Nicolas Aide, et al.
EJNMMI Reports|June 12, 2025
Systematic double reading for oncological PET/CT scans: insights from a prospective multicentre study in 678 patientsFabrice Gutman, Didier Poncin, Renaud Guedec-Ghelfi, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
EJNMMI Research|March 21, 2020
HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological <sup>18</sup>F-FDG anal uptakeNicolas Aide, Laure-Eugénie Tainturier, Cathy Nganoa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2010
18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor modelNicolas Aide, Kathryn Kinross, Carleen Cullinane, et al.
Clinical Nuclear Medicine|February 8, 2012
Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experienceRenaud Ciappuccini, Julia Morera, Pierre Pascal, et al.
Plos One|September 7, 2016
Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid CancerRenaud Ciappuccini, Nicolas Aide, David Blanchard, et al.
Diagnostics (Basel, Switzerland)|August 7, 2021
<sup>18</sup>F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University HospitalJean-Baptiste Le Goubey, Charline Lasnon, Ines Nakouri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 12, 2021
Assessing immune organs on <sup>18</sup>F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patientsKevin Prigent, Charline Lasnon, Emilien Ezine, et al.
Molecular Imaging and Biology|July 16, 2010
A dual radiologic contrast agent protocol for 18F-FDG and 18F-FLT PET/CT imaging of mice bearing abdominal tumorsNicolas Aide, Kathryn Kinross, Jean-Mathieu Beauregard, et al.
Nuclear Medicine Communications|May 9, 2013
Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenograftsPierre Bohn, Romain Modzelewski, Jean Rouvet, et al.
Nuclear Medicine Communications|April 2, 2013
Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesionsJean-Mathieu Beauregard, Anne-Laure Giraudet, Nicolas Aide, et al.
EJNMMI Reports|June 12, 2025
Systematic double reading for oncological PET/CT scans: insights from a prospective multicentre study in 678 patientsFabrice Gutman, Didier Poncin, Renaud Guedec-Ghelfi, et al.
Pageof 12